tiprankstipranks
ImmunoCellular Therapeutics (IMUC)
OTHER OTC:IMUC
US Market
IMUC
ImmunoCellular Therapeutics
RESEARCH TOOLSreports

ImmunoCellular Therapeutics (IMUC) Balance Sheet

186 Followers

ImmunoCellular Therapeutics Balance Sheet

ImmunoCellular Therapeutics's total assets for Q4 2022 were $768.80K, an increase of 7.62% from the previous quarter. IMUC total liabilities were $4.96M for the fiscal quarter, a 11.61% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 99.46K$ 389.67K$ 409.42K$ 768.80K$ 1.67M
Total Liabilities
$ 2.49M$ 1.01M$ 6.10M$ 4.96M$ 3.28M
Total Equity Gross Minority
$ -2.39M$ -617.86K$ -5.69M$ -4.19M$ -1.62M
Other Metrics
Currency in USD

ImmunoCellular Therapeutics Debt to Assets